Biora Therapeutics (BIOR) Scheduled to Post Quarterly Earnings on Thursday

Biora Therapeutics (NASDAQ:BIOR) will be issuing its quarterly earnings data after the market closes on Thursday, November 14th. Analysts expect the company to announce earnings of ($3.85) per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.

Biora Therapeutics (NASDAQ:BIOR) last issued its earnings results on Monday, August 12th. The company reported ($3.50) earnings per share (EPS) for the quarter, beating the consensus estimate of ($4.50) by $1.00. The company had revenue of $0.32 million during the quarter. On average, analysts expect Biora Therapeutics to post $-12 EPS for the current fiscal year and $-12 EPS for the next fiscal year.

Biora Therapeutics Price Performance

Shares of NASDAQ:BIOR opened at $2.70 on Wednesday. Biora Therapeutics has a 12 month low of $2.38 and a 12 month high of $19.90. The firm has a market capitalization of $9.93 million, a P/E ratio of -0.05 and a beta of 1.27. The company’s fifty day moving average price is $4.98 and its 200 day moving average price is $6.12.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reiterated a “buy” rating and set a $150.00 target price on shares of Biora Therapeutics in a research report on Tuesday, August 13th.

Biora Therapeutics Company Profile

Biora Therapeutics, Inc, a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases.